PTEN and neoplasm: In our previous work, we showed that low PTEN mRNA expression in tumor samples detected by nCounter correlated with PTEN mutations and protein expression assessed by immunohistochemistry (IHC), as well as with poor clinical outcomes of mHSPC patients [10].